The Nigeria Customs Service, Kirikiri Lighter Terminal Command, said it handed over nine containers of expired pharmaceuticals to the National Agency for Food and Drug Administration and Control.The ...

and efficacy of generic medicines in Nigeria by enforcing stringent bioequivalence studies. Speaking on Thursday in Lagos, the Director General, NAFDAC, Prof. Moji Adeyeye, said the initiative ...

Recognizing the complexity of Nigeria’s pharmaceutical market, NAFDAC is introducing the framework through a phased implementation, prioritizing essential medicines such as antimalarials ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced that all generic medicines in Nigeria must now undergo bioequivalence (BE) studies before they can be approved.

which are widely used in Nigeria. This initiative promotes public health by reducing the circulation of substandard medicines,” she added. She also revealed that NAFDAC had rolled out new ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced new regulations to ensure the safety, efficacy, and quality of generic medicines in Nigeria. This move includes ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has rolled out a groundbreaking regulatory framework requiring bioequivalence (BE) studies for all generic drug products in ...

FMs usually achieve this through any of the following options: (a) Incorporation of local subsidiaries in Nigeria for the purpose of registering their products with the NAFDAC; (b) Appointment of an ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has unveiled a new regulatory framework mandating bioequivalence (BE) studies for all generic medicines in Nigeria. The NAFDAC ...

In recent times, Nigeria has seen a wave of illegal production of fake consumer goods by unpatriotic individuals and groups who seek to make fortunes at the expense of the lives of Nigerians.

The National Agency for Food and Drug Administration and Control (NAFDAC) has unveiled a new regulatory frame – work mandating bioequivalence (BE) studies for all generic drug products in Nigeria.